Kampanjeplan Exact Sciences Corporation
Avansert tidsplan
Enkel graf
Om selskapet Exact Sciences Corporation
Exact Sciences Corporation предлагает продукты для скрининга и диагностики рака в США и за рубежом. Компания предлагает Cologuard, неинвазивный ДНК-скрининг-тест на основе стула для выявления колоректального рака и предраковых состояний. Он также предоставляет Oncotype DX, тесты экспрессии генов для рака груди, простаты и толстой кишки; и Oncotype DX AR-V7 Nucleus Detect Test, жидкий тест для рака простаты на поздней стадии. Продукция компании сосредоточена на исследованиях и разработках для улучшения рабочих характеристик Cologuard, а также на тестах крови или других жидкостей. flere detaljerIPO date | 2001-02-01 |
---|---|
ISIN | US30063P1057 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.exactsciences.com |
Цена ао | 50.34 |
Prisendring per dag: | 0% (50.34) |
---|---|
Prisendring per uke: | -7.26% (54.28) |
Prisendring per måned: | -7.12% (54.2) |
Prisendring over 3 måneder: | -1.16% (50.93) |
Prisendring over seks måneder: | -14.63% (58.97) |
Prisendring per år: | -17.6% (61.09) |
Prisendring over 3 år: | -29.42% (71.32) |
Prisendring over 5 år: | -45.73% (92.75) |
Prisendring over 10 år: | +110.72% (23.89) |
Prisendring siden begynnelsen av året: | -14.58% (58.93) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Transaksjonsdato | Avsløringsdato | Insider | Type | Pris | Volum | Mengde | Del opp til, % | Del etterpå, % | Dokument |
---|---|---|---|---|---|---|---|---|---|
01.05.2024 | 02.05.2024 | Conroy Kevin T President and CEO |
Salg | 60.15 | 69 473 | 1155 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | ORVILLE JACOB A General Manager, Screening |
Salg | 60.15 | 6 135 | 102 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | Condella Sarah EVP, Human Resources |
Salg | 60.15 | 6 135 | 102 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | Baranick Brian EVP, GM., Precision Oncology |
Salg | 60.15 | 6 617 | 110 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | Elliott Jeffrey Thomas Chief Financial Officer |
Salg | 60.15 | 8 180 | 136 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | Herriott James SVP, General Counsel & Sec |
Salg | 60.15 | 1 805 | 30 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | Cunningham Everett Chief Commercial Officer |
Salg | 60.15 | 8 180 | 136 | 0 | 0 | link |
01.05.2024 | 02.05.2024 | COWARD D SCOTT Director |
Salg | 60.15 | 4 030 | 67 | 0 | 0 | link |
28.03.2024 | 01.04.2024 | Condella Sarah EVP, Human Resources |
Salg | 70 | 140 000 | 2000 | 0 | 0 | link |
22.02.2024 | 23.02.2024 | COWARD D SCOTT Director |
Salg | 59.78 | 39 634 | 663 | 0 | 0 | link |
22.02.2024 | 23.02.2024 | Cunningham Everett Chief Commercial Officer |
Salg | 59.78 | 80 703 | 1350 | 0 | 0 | link |
22.02.2024 | 23.02.2024 | Elliott Jeffrey Thomas Chief Financial Officer |
Salg | 59.78 | 80 763 | 1351 | 0 | 0 | link |
22.02.2024 | 23.02.2024 | Herriott James General Counsel |
Salg | 59.78 | 17 396 | 291 | 0 | 0 | link |
22.02.2024 | 23.02.2024 | ORVILLE JACOB A General Manager, Screening |
Salg | 59.78 | 60 557 | 1013 | 0 | 0 | link |
01.09.2023 | 06.09.2023 | Condella Sarah EVP, Human Resources |
Salg | 84.36 | 379 620 | 4500 | 0 | 0 | link |
12.10.2022 | 13.10.2022 | Cunningham Everett Chief Commercial Officer |
Salg | 31.37 | 529 275 | 16872 | 0 | -0.01 | link |
11.10.2022 | 13.10.2022 | Cunningham Everett Chief Commercial Officer |
Kjøpe | 30.42 | 1 064 880 | 35006 | 0 | 0.02 | link |
10.06.2021 | 11.06.2021 | Condella Sarah SVP, Human Resources |
Salg | 120 | 654 000 | 5450 | 0 | 0 | link |
10.06.2021 | 11.06.2021 | Condella Sarah SVP, Human Resources |
Kjøpe | 5.03 | 9 809 | 1950 | 0 | 0 | link |
25.02.2021 | 01.03.2021 | COWARD D SCOTT Chief Administrative Officer |
Salg | 132.96 | 902 532 | 6788 | 0 | -0.01 | link |
19.02.2021 | 22.02.2021 | ORVILLE JACOB A General Manager, New Ventures |
Salg | 143.38 | 243 172 | 1696 | 0 | 0 | link |
18.02.2021 | 22.02.2021 | COWARD D SCOTT Chief Administrative Officer |
Salg | 140.79 | 278 764 | 1980 | 0 | 0 | link |
18.02.2021 | 22.02.2021 | ORVILLE JACOB A General Manager, New Ventures |
Kjøpe | 142.32 | 519 326 | 3649 | 0 | 0 | link |
14.12.2020 | 14.12.2020 | Zanotti Katherine S Director |
Salg | 132.06 | 2 641 200 | 20000 | 0 | -0.02 | link |
Institusjoner | Volum | Dele, % |
---|---|---|
Vanguard Group Inc | 17559751 | 9.67 |
JP Morgan Chase & Company | 16690808 | 9.19 |
Blackrock Inc. | 11053013 | 6.09 |
Wellington Management Group, LLP | 10280814 | 5.66 |
Capital World Investors | 7468145 | 4.11 |
ARK Investment Management, LLC | 6032893 | 3.32 |
State Street Corporation | 5020742 | 2.77 |
Artisan Partners Limited Partnership | 4470278 | 2.46 |
Baillie Gifford and Company | 3767055 | 2.08 |
T. Rowe Price Investment Management, Inc. | 2951302 | 1.63 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Kevin T. Conroy | Chairman of The Board & CEO | 1.54M | 1966 (59 år) |
Ms. Megan Jones | Associate Manager of Investor Relations | N/A | |
Mr. Tim Caprez | Chief Compliance Counsel & VP | N/A | |
Dr. Jorge A. Garces Ph.D. | Chief Science Officer | N/A | 1972 (53 år) |
Mr. James Herriott | Senior VP, General Counsel & Secretary | N/A | 1980 (45 år) |
Ms. Sarah Condella | Executive Vice President of Human Resources | 742.76k | 1981 (44 år) |
Mr. Nassar Nizami | Chief Information Officer | N/A | |
Mr. Jake Orville MBA | Executive VP & General Manager of Pipeline | 1974 (51 år) | |
Mr. Brian Baranick | Executive VP & General Manager of Precision Oncology | 1978 (47 år) | |
Mr. Aaron Bloomer | Chief Financial Officer | 1986 (39 år) |
Adresse: United States, Madison, WI , 5505 Endeavor Lane - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.exactsciences.com
Nettsted: http://www.exactsciences.com